Skip to content

Investigating the effect of vitamin D on benign positional vertigo in patients

Investigating the effect of vitamin D on benign positional vertigo in patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250726066643N1
Enrollment
38
Registered
2025-08-10
Start date
2025-08-11
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign positional vertigo. Dizziness and giddiness

Interventions

Intervention 1: The intervention group of the study: Due to vitamin D deficiency in both the intervention and control groups, in addition to receiving treatment for benign positional vertigo as prescr

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with benign paroxysmal positional vertigo (BPPV) who visited the neurology clinic in were found to have vitamin D deficiency based on blood tests conducted in the past three months Presentation with symptoms of a benign paroxysmal positional vertigo (BPPV) attack

Exclusion criteria

Exclusion criteria: Non-consent to participate in the study Patients with severe vitamin D deficiency that requires immediate treatment Patients who do not comply with the given treatment regimen

Design outcomes

Primary

MeasureTime frame
Number of dizziness attacks. Timepoint: 0,4 weeks after starting vitamin D supplementation. Method of measurement: Clinical interview.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Sara Rezaei

Islamic Azad University

Ssara_rz@yahoo.com+98 21 2200 6660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026